T2 Biosystems, Inc. (NASDAQ:TTOO) shares traded lower Tuesday as the stock pulled back following Monday’s strength after the FDA cleared the company’s biothreat panel for commercial distribution.
What To Know: Shares of T2 Biosystems received a boost Monday following the FDA clearance which will allow the company to immediately start marketing and selling the T2Biothreat Panel, a direct-from-blood molecular diagnostic test, in the U.S. market.
However, T2 Biosystems stock pulled back Tuesday by over 26% following Monday’s gain.
Related Link: What’s Going On With Intel Stock?
TTOO Price Action: Shares of TTOO were gaining back 5.3% to trade at 39 cents in the after-hours session, according to Benzinga Pro.
Image by MasterTux from Pixabay.
